Pricing Log in Create free account

CorMedix Inc (CRMD) vs Zevra Therapeutics, Inc. (ZVRA)

CorMedix Inc and Zevra Therapeutics, Inc. are both Biotechnology companies. CorMedix Inc and Zevra Therapeutics, Inc. are of similar size ($609.9M and $581.5M). CorMedix Inc trades at the lower P/E: 3.0× against 10.5×. CorMedix Inc grew revenue faster over the last twelve months: 280.5% against 119.4%. Zevra Therapeutics, Inc. has the higher net margin (42.3% vs 40.5%) and the lower return on invested capital (0.00% vs 38.8%). Across the 21 metrics below, CorMedix Inc leads on 16 and Zevra Therapeutics, Inc. on 5.

Valuation

Metric CRMD ZVRA Biotechnology median
P/E 3.01 10.47 8.50
P/S 1.23 4.33 9.71
P/B 1.24 2.70 2.13
Price to free cash flow 2.27 17.80 20.82
EV/EBITDA 1.81 5.79 0.64
EV/Sales 0.99 3.43 9.21
Earnings yield 33.20% 9.55% (33.15%)
Free cash flow yield 43.97% 5.62% (25.50%)

Profitability

Metric CRMD ZVRA Biotechnology median
Gross margin 82.78% 95.46% 65.16%
Operating margin 46.95% 60.54% 0.00%
Net margin 40.49% 42.25% 0.00%
Free cash flow margin 54.17% 24.30% 0.00%
Return on equity 54.93% 34.33% (56.36%)
Return on assets 32.36% 20.57% (48.04%)
Return on invested capital 38.84% 0.00% 0.00%

Growth

Metric CRMD ZVRA Biotechnology median
Revenue growth (TTM) 280.50% 119.40% 6.02%
EPS growth (last fiscal year) 780.00% 159.21% 30.26%
Revenue growth, 5-year CAGR 305.79% 51.62% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRMD ZVRA Biotechnology median
Debt to equity 0.32 0.00 0.00
Current ratio 2.56 5.17 4.72
Net debt to EBITDA (0.02) 39.03 0.96

Dividend

Metric CRMD ZVRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRMD ZVRA Biotechnology median
Market cap 581.47m 609.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack